Diana Lee

机构：Moderna Therapeutics (United States)

发表论文 102 篇 · 总被引 6480 次 · h-index 27

代表论文

• Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines (2023 · medRxiv · 被引 79)
• Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB–Containing Vaccines (2024 · The Journal of Infectious Diseases · 被引 64)
• Viral evolution prediction identifies broadly neutralizing antibodies to existing and prospective SARS-CoV-2 variants (2025 · Nature Microbiology · 被引 40)
• mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice (2025 · Vaccine · 被引 15)
• Viral evolution prediction identifies broadly neutralizing antibodies against existing and prospective SARS-CoV-2 variants (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 15)
• Predictive modeling of immune escape and antigenic grouping of SARS-CoV-2 variants (2026 · Journal of Virology · 被引 5)